News from endo international plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 27, 2018, 06:00 ET Endo Reports Fourth-Quarter And Full-Year 2017 Financial Results

Fourth-quarter 2017 revenues of $769 million; Full-year 2017 revenues of $3,469 million Fourth-quarter 2017 Sterile Injectables revenues increased 16 percent to $167 million; Full-year 2017 Sterile...


Feb 06, 2018, 07:30 ET Endo Announces Initiation Of Two Pivotal Phase 3 Clinical Trials Of Collagenase Clostridium Histolyticum For The Treatment Of Cellulite

Endo International plc (NASDAQ: ENDP) today announced the initiation of two identical Phase 3 RELEASE* clinical trials of collagenase clostridium histolyticum (CCH) for the treatment of cellulite....


Jan 29, 2018, 07:30 ET Endo to Announce Fourth-Quarter 2017 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter 2017 financial results on February 27, 2018 and members of its senior management team will host a conference call and webcast...


Jan 24, 2018, 17:03 ET Endo Agrees to FDA's Request to Seek Temporary Litigation Stay

Endo International plc (NASDAQ: ENDP) today announced that it has agreed to a request by the U.S. Food and Drug Administration (FDA) to seek a temporary stay of the litigation initiated against FDA...


Jan 11, 2018, 08:30 ET Endo Comments on United States Attorney's Office Grand Jury Subpoena Relating to Products Containing Oxymorphone

Endo International plc (NASDAQ: ENDP) ("Endo") today announced that its subsidiary, Endo Pharmaceuticals Inc. ("EPI"), has received a grand jury subpoena from the United States Attorney's Office for...


Dec 28, 2017, 08:30 ET Endo to Participate at the 36th Annual J.P. Morgan Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that Paul Campanelli, President and CEO, will participate in a fireside chat at the 36th Annual J.P. Morgan Healthcare Conference in San...


Nov 17, 2017, 16:01 ET Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

Endo International plc (NASDAQ: ENDP) announced today that Blaise Coleman, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Bank of America Merrill...


Nov 09, 2017, 16:01 ET Endo Reports Third-Quarter 2017 Financial Results

Third-quarter 2017 revenues of $787 million and reported $0.45 diluted (GAAP) loss per share from continuing operations Third-quarter 2017 adjusted diluted earnings per share (EPS) from continuing...


Nov 08, 2017, 16:43 ET Endo Announces Appointment of Dr. Sharad S. Mansukani to Board of Directors and Resignation of Mr. Douglas S. Ingram

Endo International plc (NASDAQ: ENDP) today announced the appointment of Sharad S. Mansukani, M.D., CPE, CMCE to the Company's Board of Directors effective immediately. Endo also announced Douglas S. ...


Oct 30, 2017, 08:30 ET Endo Announces Certain Preliminary Financial Results for Third-Quarter 2017 and Affirms Selected 2017 Financial Guidance

Endo International plc (NASDAQ: ENDP) today announced certain preliminary results for the quarter ended September 30, 2017, including expected: (i) revenues of approximately $785 million; (ii)...


Oct 26, 2017, 16:40 ET Endo Files Federal Lawsuit to Obtain FDA Compliance with Drug Quality and Security Act of 2013

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Par Sterile Products, LLC and Endo Par Innovation Company, LLC, filed suit in the United States District Court for the...


Oct 25, 2017, 16:30 ET Endo Completes Divestiture of Grupo Farmacéutico SOMAR

Endo International plc (NASDAQ: ENDP) today announced the completion of the previously announced sale of Grupo Farmacéutico SOMAR to Advent International for a purchase price of approximately $124...


Oct 09, 2017, 07:30 ET Endo to Announce Third-Quarter 2017 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its third-quarter 2017 financial results on November 9, 2017 and members of its senior management team will host a conference call and webcast...


Sep 26, 2017, 06:30 ET Four-Time PGA TOUR Winner Tim Herron Teams Up with Endo Pharmaceuticals to Encourage Adults to Get the Facts on Hand

Four-time PGA TOUR winner Tim Herron is teaming up with Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), Damon Adamany, MD, of The CORE Institute and the Facts on...


Aug 28, 2017, 07:30 ET Endo Begins Shipment of Generic Sabril® (vigabatrin) for Oral Solution

Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, has begun shipping vigabatrin for oral solution USP, 500 mg per packet following final...


Aug 22, 2017, 07:30 ET Endo to Participate at Morgan Stanley Global Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that Paul Campanelli, President and CEO, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference in New York on...


Aug 08, 2017, 06:30 ET Endo Reports Second-Quarter 2017 Financial Results

Second-quarter 2017 revenues of $876 million and reported $3.12 diluted (GAAP) loss per share from continuing operations Second-quarter 2017 Branded Specialty Products revenues increased 16 percent...


Aug 07, 2017, 16:30 ET Endo Announces Agreements to Resolve Virtually All Known U.S. Mesh Product Liability Claims

Endo International plc (NASDAQ: ENDP) today announced that it has reached agreements to resolve virtually all known U.S. mesh product liability claims and that it is engaged in discussions to resolve ...


Jul 21, 2017, 08:30 ET Endo to Restructure Manufacturing Network

Endo International plc (NASDAQ: ENDP) today announced that after completing a comprehensive review of its manufacturing network, the Company will be ceasing operations and closing its manufacturing...


Jul 14, 2017, 07:30 ET Endo to Announce Second-Quarter 2017 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its second-quarter 2017 financial results on Tuesday, August 8, 2017. Members of its senior management team will host a conference call and webcast ...


Jul 06, 2017, 12:15 ET Endo Provides Update On OPANA® ER

Endo International plc (NASDAQ: ENDP) continues to believe in the safety, efficacy, and favorable benefit-risk profile of OPANA® ER (oxymorphone hydrochloride extended release) when used as intended, ...


Jul 05, 2017, 07:30 ET Endo Announces Divestiture of Grupo Farmacéutico SOMAR

Endo International plc (NASDAQ: ENDP) today announced it has entered into a definitive agreement to sell Mexico City based Grupo Farmacéutico SOMAR to Advent International for approximately $124...


Jul 03, 2017, 13:45 ET Endo Completes Divestiture of Litha Healthcare Group

Endo International plc (NASDAQ: ENDP) today announced that it has completed the previously announced divestiture of its South African based operations, Litha Healthcare Group, to Acino Pharma AG. In...


Jun 08, 2017, 17:47 ET Endo Response to June 8, 2017 FDA Meeting Related to OPANA® ER

Endo International plc (NASDAQ: ENDP) is aware of today's announcement by the U.S. Food and Drug Administration (FDA) requesting that Endo voluntarily withdraw OPANA® ER (oxymorphone hydrochloride...


Jun 07, 2017, 17:12 ET Endo Announces Entry of Significant Case Management Order in Mesh Multidistrict Litigation

Endo International plc (NASDAQ: ENDP) today announced that on June 7, 2017, the Hon. Joseph R. Goodwin, U.S. District Court Judge for the Southern District of West Virginia, entered a case management ...